Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

289.90 +2.03 (+0.71%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
Via Benzinga
3 Dividend-Paying ETFs to Secure Your Passive Income Stream
Passive income and ETFs represent two compelling market concepts. Why not bring the two together with dividend-paying ETFs? 
Via InvestorPlace
Topics ETFs
Unpacking the Latest Options Trading Trends in Amgen
Via Benzinga
Market Whales and Their Recent Bets on AMGN Options
Via Benzinga
3 Fabulous Growth Stocks to Buy and Hold Forever
The bull market in growth stocks is more than just chipmakers if investors will only widen their lens to see the opportunities available. 
Via InvestorPlace
Unpacking the Latest Options Trading Trends in Amgen
Via Benzinga
A Closer Look at Amgen's Options Market Dynamics
Via Benzinga
Check Out What Whales Are Doing With AMGN
Via Benzinga
7 Biotech Stocks to Keep on Your Clinical Radar
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs. 
Via InvestorPlace
3 Stocks That Are Melting Up. Is There Room to Run?
Buying stocks while they're melting up isn't without its fair share of risk. That said, these high-flyers look pretty enticing. 
Via InvestorPlace
10 Best Dividend Growth Stocks to Buy and Hold Forever
Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance. 
Via The Motley Fool
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
The Nasdaq tumbled amid chip woes. 
Via Investor's Business Daily
Q2 Earnings Season Scorecard, Economic Outlook And Analyst Reports For Nvidia, Meta & Others
Today's Research Daily features a real-time update on the Q2 earnings season, the July Economic Outlook monthly, and new research reports on 16 major stocks, including NVIDIA, Meta, and Amgen as well... 
Via Talk Markets
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry. 
Via Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
Roche released early-stage data on its oral weight-loss drug. 
Via Investor's Business Daily
7 Dividend Stocks That Just Raised Their Payouts: July 2024
Dividend stocks have a long history of outperforming non-dividend-paying stocks, but those that increase their payout do even better. 
Via InvestorPlace
Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense
Biogen has $8 billion to $10 billion in dry powder for acquisitions. Here are three names the company could examine. 
Via Investor's Business Daily
3 Quantum AI Stocks That Could Redefine Computing
Three quantum AI stocks could shape the future of computing, which means current market prices are very cheap. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Biotech Stocks to Buy Now: Q3 Edition
Biotech stocks to buy can be a strong portfolio addition due to their capability for rapid growth within an evolving industry. 
Via InvestorPlace
CPI Data Sparks Rally in Biotech Stocks
Following lower-than-expected inflation data on Thursday, The biotech sector broke out above resistance, closing the week up 6%, far outperforming the market. 
Via MarketBeat
Topics ETFs Economy
Exposures Interest Rates
What Is the Dividend Payout for Amgen Stock?
Amgen offers a packed pipeline and healthy dividend distributions. 
Via The Motley Fool
Positive News is Driving This Cancer Drug Maker’s Stock Higher
IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather 
Via MarketBeat
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Revenue is climbing at these two drug companies -- and the trend should continue. 
Via The Motley Fool
3 Dividend Growth Stocks to Buy and Hold
What's better than a dividend? A dividend that's growing. 
Via The Motley Fool
Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
Megacaps and chip plays tumbled Thursday, but mostly still have healthy charts. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
TSLA Hit Our Target - Here’s What’s Next
We’ll look at another big mover right now: precious metals. They still look good after Fed Chair Jerome Powell tried to talk down rate cuts today. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
7 Cheap Biotech Stocks With Major Upside Potential
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks. 
Via InvestorPlace
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
This pharma company is posting double-digit revenue growth. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.